Ardelyx Inc (ARDX)
8.70
+1.91
(+28.13%)
USD |
NASDAQ |
May 03, 16:00
8.70
0.00 (0.00%)
After-Hours: 18:29
Ardelyx Profit Margin (Quarterly): -83.82% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -83.82% |
| September 30, 2023 | 11.76% |
| June 30, 2023 | -76.66% |
| March 31, 2023 | -235.5% |
| December 31, 2022 | 24.21% |
| September 30, 2022 | -459.1% |
| June 30, 2022 | -1.07K% |
| March 31, 2022 | -6.00K% |
| December 31, 2021 | -3.52K% |
| September 30, 2021 | -3.72K% |
| June 30, 2021 | -3.44K% |
| March 31, 2021 | -503.7% |
| December 31, 2020 | -1.60K% |
| September 30, 2020 | -667.5% |
| June 30, 2020 | -1.36K% |
| March 31, 2020 | -1.84K% |
| December 31, 2019 | -879.6% |
| September 30, 2019 | -781.2% |
| June 30, 2019 | -141.5K% |
| March 31, 2019 | |
| December 31, 2018 | -32.78K% |
| September 30, 2018 | -14.03K% |
| Date | Value |
|---|---|
| June 30, 2018 | -74.30K% |
| March 31, 2018 | -733.6% |
| December 31, 2017 | 24.08% |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | 49.64% |
| March 31, 2015 | -59.53% |
| December 31, 2014 | -62.64% |
| September 30, 2014 | 0.97% |
| June 30, 2014 | 41.07% |
| March 31, 2014 | -35.92% |
| December 31, 2013 | -50.29% |
| September 30, 2013 | -14.17% |
| June 30, 2013 | -12.22% |
| March 31, 2013 | -7.17% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-141.5K%
Minimum
Jun 2019
24.21%
Maximum
Dec 2022
-8.83K%
Average
-879.6%
Median
Dec 2019
Profit Margin (Quarterly) Benchmarks
| Nektar Therapeutics | -176.2% |
| Omeros Corp | -- |
| Vistagen Therapeutics Inc | -1.54K% |
| Karyopharm Therapeutics Inc | -124.0% |
| Adverum Biotechnologies Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -46.86% |
| Return on Assets | -27.41% |
| Return on Invested Capital | -38.30% |
| Gross Profit Margin (Quarterly) | 85.23% |
| Operating Margin (Quarterly) | -81.44% |
| Return on Net Operating Assets | -120.1% |